Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 5140679, 7 pages
https://doi.org/10.1155/2017/5140679
Review Article

Thrombosis, Neuroinflammation, and Poststroke Infection: The Multifaceted Role of Neutrophils in Stroke

1Department of Neurology, University Medicine Greifswald, Greifswald, Germany
2Department of Neurology, Carl-Thiem-Klinikum, Cottbus, Germany

Correspondence should be addressed to Antje Vogelgesang; ed.dlawsfierg-inu@gnaseglegov.ejtna

Received 14 December 2016; Revised 8 February 2017; Accepted 9 February 2017; Published 26 February 2017

Academic Editor: Carlos Rosales

Copyright © 2017 Johanna Ruhnau et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. C. Miller and M. S. V. Elkind, “Infection and stroke: an update on recent progress,” Current Neurology and Neuroscience Reports, vol. 16, no. 1, article no. 2, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Ding, “Endovascular mechanical thrombectomy for acute ischemic stroke: a new standard of care,” Journal of Stroke, vol. 17, no. 2, pp. 123–126, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. J. P. Broderick, Y. Y. Palesch, A. M. Demchuk et al., “Endovascular therapy after intravenous t-PA versus t-PA alone for stroke,” New England Journal of Medicine, vol. 368, no. 10, pp. 893–903, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. C. S. Kidwell, R. Jahan, J. Gornbein et al., “A trial of imaging selection and endovascular treatment for ischemic stroke,” New England Journal of Medicine, vol. 368, no. 10, pp. 914–923, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Ciccone, L. Valvassori, M. Nichelatti et al., “Endovascular treatment for acute ischemic stroke,” New England Journal of Medicine, vol. 368, no. 10, pp. 904–913, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Goyal, A. M. Demchuk, B. K. Menon et al., “Randomized assessment of rapid endovascular treatment of ischemic stroke,” The New England Journal of Medicine, vol. 372, no. 11, pp. 1019–1030, 2015. View at Google Scholar
  7. T. G. Jovin, A. Chamorro, E. Cobo et al., “Thrombectomy within 8 hours after symptom onset in ischemic stroke,” New England Journal of Medicine, vol. 372, no. 24, pp. 2296–2306, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Saver, M. Goyal, A. Bonafe et al., “Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke,” New England Journal of Medicine, vol. 372, no. 24, pp. 2285–2295, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. B. C. Campbell, P. J. Mitchell, T. J. Kleinig et al., “Endovascular therapy for ischemic stroke with perfusion-imaging selection,” New England Journal of Medicine, vol. 372, no. 11, pp. 1009–1018, 2015. View at Publisher · View at Google Scholar
  10. J. Mocco, O. O. Zaidat, R. von Kummer et al., “Aspiration thrombectomy after intravenous alteplase versus intravenous alteplase alone,” Stroke, vol. 47, no. 9, pp. 2331–2338, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Bracard, X. Ducrocq, J. L. Mas et al., “Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial,” The Lancet Neurology, vol. 15, no. 11, pp. 1138–1147, 2016. View at Publisher · View at Google Scholar
  12. Á. Chamorro, A. Meisel, A. M. Planas, X. Urra, D. Van De Beek, and R. Veltkamp, “The immunology of acute stroke,” Nature Reviews Neurology, vol. 8, no. 7, pp. 401–410, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Vogelgesang, K. J. Becker, and A. Dressel, “Immunological consequences of ischemic stroke,” Acta Neurologica Scandinavica, vol. 129, no. 1, pp. 1–12, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. D. J. H. McCabe, P. Harrison, I. J. Mackie et al., “Increased platelet count and leucocyte-platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosis,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 9, pp. 1249–1254, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. L. S. Ritter, K. M. Stempel, B. M. Coull, and P. F. McDonagh, “Leukocyte-platelet aggregates in rat peripheral blood after ischemic stroke and reperfusion,” Biological Research for Nursing, vol. 6, no. 4, pp. 281–288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Hallevi, I. Hazan-Halevy, and E. Paran, “Modification of neutrophil adhesion to human endothelial cell line in acute ischemic stroke by dipyridamole and candesartan,” European Journal of Neurology, vol. 14, no. 9, pp. 1002–1007, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Faraday, K. Schunke, S. Saleem et al., “Cathepsin G-dependent modulation of platelet thrombus formation in vivo by blood neutrophils,” PLOS ONE, vol. 8, no. 8, Article ID e71447, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. M. M. Khan, D. G. Motto, S. R. Lentz, and A. K. Chauhan, “ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice,” Journal of Thrombosis and Haemostasis, vol. 10, no. 8, pp. 1665–1671, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. T. A. Fuchs, A. Brill, D. Duerschmied et al., “Extracellular DNA traps promote thrombosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 36, pp. 15880–15885, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Brinkmann and A. Zychlinsky, “Beneficial suicide: why neutrophils die to make NETs,” Nature Reviews Microbiology, vol. 5, no. 8, pp. 577–582, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Semeraro, C. T. Ammollo, J. H. Morrissey et al., “Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4,” Blood, vol. 118, no. 7, pp. 1952–1961, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Sreeramkumar, J. M. Adrover, I. Ballesteros et al., “Neutrophils scan for activated platelets to initiate inflammation,” Science, vol. 346, no. 6214, pp. 1234–1238, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Maugeri, L. Campana, M. Gavina et al., “Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps,” Journal of Thrombosis and Haemostasis, vol. 12, no. 12, pp. 2074–2088, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. S. F. De Meyer, F. Denorme, F. Langhauser, E. Geuss, F. Fluri, and C. Kleinschnitz, “Thromboinflammation in stroke brain damage,” Stroke, vol. 47, no. 4, pp. 1165–1172, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. S. F. De Meyer, G. L. Suidan, T. A. Fuchs, M. Monestier, and D. D. Wagner, “Extracellular chromatin is an important mediator of ischemic stroke in mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 8, pp. 1884–1891, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Neumann, M. Riek-Burchardt, J. Herz et al., “Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke,” Acta Neuropathologica, vol. 129, no. 2, pp. 259–277, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. G. C. Jickling, D. Liu, B. P. Ander, B. Stamova, X. Zhan, and F. R. Sharp, “Targeting neutrophils in ischemic stroke: translational insights from experimental studies,” Journal of Cerebral Blood Flow and Metabolism, vol. 35, no. 6, pp. 888–901, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Tang, Y. Liu, Z. Zhang et al., “Mesenchymal stem cells maintain blood-brain barrier integrity by inhibiting aquaporin-4 upregulation after cerebral ischemia,” Stem Cells, vol. 32, no. 12, pp. 3150–3162, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Neumann, S. Sauerzweig, R. Rönicke et al., “Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege,” Journal of Neuroscience, vol. 28, no. 23, pp. 5965–5975, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Rørvig, C. Honore, L.-I. Larsson et al., “Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP,” Journal of Leukocyte Biology, vol. 86, no. 6, pp. 1439–1449, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Perez-de-Puig, F. Miró-Mur, M. Ferrer-Ferrer et al., “Neutrophil recruitment to the brain in mouse and human ischemic stroke,” Acta Neuropathologica, vol. 129, no. 2, pp. 239–257, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. A. M. Stowe, T. L. Adair-Kirk, E. R. Gonzales et al., “Neutrophil elastase and neurovascular injury following focal stroke and reperfusion,” Neurobiology of Disease, vol. 35, no. 1, pp. 82–90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Herz, P. Sabellek, T. E. Lane, M. Gunzer, D. M. Hermann, and T. R. Doeppner, “Role of neutrophils in exacerbation of brain injury after focal cerebral ischemia in hyperlipidemic mice,” Stroke, vol. 46, no. 10, pp. 2916–2925, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Gelderblom, A. Weymar, C. Bernreuther et al., “Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke,” Blood, vol. 120, no. 18, pp. 3793–3802, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. E. D. O. Ferreira, M. Y. S. D. Fernandes, N. M. R. D. Lima et al., “Neuroinflammatory response to experimental stroke is inhibited by eriodictyol,” Behavioural Brain Research, vol. 312, pp. 321–332, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Yu, Y. Liang, Z. Huang, D. W. Jones, K. A. Pritchard, and H. Zhang, “Inhibition of myeloperoxidase oxidant production by N-acetyl lysyltyrosylcysteine amide reduces brain damage in a murine model of stroke,” Journal of Neuroinflammation, vol. 13, no. 1, article 119, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. R. M. Weston, B. Jarrott, Y. Ishizuka, and J. K. Callaway, “AM-36 modulates the neutrophil inflammatory response and reduces breakdown of the blood brain barrier after endothelin-1 induced focal brain ischaemia,” British Journal of Pharmacology, vol. 149, no. 6, pp. 712–723, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Garcia-Bonilla, J. M. Moore, G. Racchumi et al., “Inducible nitric oxide synthase in neutrophils and endothelium contributes to ischemic brain injury in mice,” Journal of Immunology, vol. 193, no. 5, pp. 2531–2537, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Mishina, Y. Komaba, S. Kobayashi et al., “Efficacy of edaravone, a free radical scavenger, for the treatment of acute lacunar infarction,” Neurologia Medico-Chirurgica, vol. 45, no. 7, pp. 344–348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Mishina, Y. Komaba, S. Kobayashi et al., “Administration of free radical scavenger edaravone associated with higher frequency of hemorrhagic transformation in patients with cardiogenic embolism,” Neurologia Medico-Chirurgica, vol. 48, no. 7, pp. 292–297, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. R. H. Mehta, M. Cox, E. E. Smith et al., “Race/ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy,” Stroke, vol. 45, no. 8, pp. 2263–2269, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Li, C. Huang, J. Chen, Y. Guo, and S. Tan, “The role of uric acid as a potential neuroprotectant in acute ischemic stroke: a review of literature,” Neurological Sciences, vol. 36, no. 7, pp. 1097–1103, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. Á. Chamorro, V. Obach, Á. Cervera, M. Revilla, R. Deulofeu, and J. H. Aponte, “Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke,” Stroke, vol. 33, no. 4, pp. 1048–1052, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Chiquete, J. L. Ruiz-Sandoval, L. M. Murillo-Bonilla et al., “Serum uric acid and outcome after acute ischemic stroke: premier study,” Cerebrovascular Diseases, vol. 35, no. 2, pp. 168–174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Llull, C. Laredo, A. Renú et al., “Uric acid therapy improves clinical outcome in women with acute ischemic stroke,” Stroke, vol. 46, no. 8, pp. 2162–2167, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. M. G. Lansberg, G. W. Albers, and C. A. C. Wijman, “Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors,” Cerebrovascular Diseases, vol. 24, no. 1, pp. 1–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Schulze, D. Zierath, P. Tanzi et al., “Severe stroke induces long-lasting alterations of high-mobility group box 1,” Stroke, vol. 44, no. 1, pp. 246–248, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Huebener, J.-P. Pradere, C. Hernandez et al., “The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis,” The Journal of Clinical Investigation, vol. 125, no. 2, pp. 539–550, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. J.-M. Tadie, H.-B. Bae, S. Jiang et al., “HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 304, no. 5, pp. L342–L349, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Hayakawa, K. Mishima, K. Irie et al., “Cannabidiol prevents a post-ischemic injury progressively induced by cerebral ischemia via a high-mobility group box1-inhibiting mechanism,” Neuropharmacology, vol. 55, no. 8, pp. 1280–1286, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Prass, C. Meisel, C. Höflich et al., “Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell Type 1-like immunostimulation,” Journal of Experimental Medicine, vol. 198, no. 5, pp. 725–736, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Muhammad, W. Barakat, S. Stoyanov et al., “The HMGB1 receptor RAGE mediates ischemic brain damage,” Journal of Neuroscience, vol. 28, no. 46, pp. 12023–12031, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. Z. Guo, S. Yu, L. Xiao et al., “Dynamic change of neutrophil to lymphocyte ratio and hemorrhagic transformation after thrombolysis in stroke,” Journal of Neuroinflammation, vol. 13, no. 1, article no. 199, 2016. View at Publisher · View at Google Scholar · View at Scopus
  54. I. Maestrini, D. Strbian, S. Gautier et al., “Higher neutrophil counts before thrombolysis for cerebral ischemia predict worse outcomes,” Neurology, vol. 85, no. 16, pp. 1408–1416, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. F. Wang, S. Hu, Y. Ding et al., “Neutrophil-to-lymphocyte ratio and 30-day mortality in patients with acute intracerebral hemorrhage,” Journal of Stroke and Cerebrovascular Diseases, vol. 25, no. 1, pp. 182–187, 2016. View at Publisher · View at Google Scholar · View at Scopus
  56. F. Carbone, N. Vuilleumier, M. Bertolotto et al., “Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways,” Vascular Pharmacology, vol. 64, pp. 16–27, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Minnerup, J. Heidrich, J. Wellmann, A. Rogalewski, A. Schneider, and W.-R. Schabitz, “Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia,” Stroke, vol. 39, no. 6, pp. 1855–1861, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. T. J. England, N. Sprigg, A. M. Alasheev et al., “Granulocyte-Colony Stimulating Factor (G-CSF) for stroke: an individual patient data meta-analysis,” Scientific Reports, vol. 6, Article ID 36567, 2016. View at Publisher · View at Google Scholar
  59. S. Gautier, T. Ouk, M. Tagzirt et al., “Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke,” Journal of Neuroinflammation, vol. 11, article 96, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Morrison, D. McKee, and L. Ritter, “Systemic neutrophil activation in a mouse model of ischemic stroke and reperfusion,” Biological Research for Nursing, vol. 13, no. 2, pp. 154–163, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. W. Saliba, O. Barnett-Griness, M. Elias, and G. Rennert, “Neutrophil to lymphocyte ratio and risk of a first episode of stroke in patients with atrial fibrillation: A Cohort Study,” Journal of Thrombosis and Haemostasis, vol. 13, no. 11, pp. 1971–1979, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. E. Köklü, I. Ö. Yüksel, Ş. Arslan et al., “Is elevated neutrophil-to-lymphocyte ratio a predictor of stroke in patients with intermediate carotid artery stenosis?” Journal of Stroke and Cerebrovascular Diseases, vol. 25, no. 3, pp. 578–584, 2016. View at Publisher · View at Google Scholar · View at Scopus
  63. İ. Ö. Yüksel, E. Köklü, Ş. Arslan et al., “Association of neutrophil/lymphocyte ratio with plaque morphology in patients with asymptomatic intermediate carotid artery stenosis,” Korean Circulation Journal, vol. 46, no. 5, pp. 699–705, 2016. View at Publisher · View at Google Scholar
  64. N. L. Chiu, B. Kaiser, Y. V. Nguyen, S. Welbourne, C. Lall, and S. C. Cramer, “The volume of the spleen and its correlates after acute stroke,” Journal of Stroke and Cerebrovascular Diseases, vol. 25, no. 12, pp. 2958–2961, 2016. View at Publisher · View at Google Scholar
  65. G. Courties, F. Herisson, H. B. Sager et al., “Ischemic stroke activates hematopoietic bone marrow stem cells,” Circulation Research, vol. 116, no. 3, pp. 407–417, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. X. Urra, Á. Cervera, V. Obach, N. Climent, A. M. Planas, and A. Chamorro, “Monocytes are major players in the prognosis and risk of infection after acute stroke,” Stroke, vol. 40, no. 4, pp. 1262–1268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. A. A. Wong, J. P. Davis, P. J. Schluter, R. D. Henderson, J. D. O'Sullivan, and S. J. Read, “The time course and determinants of temperature within the first 48 h after ischaemic stroke,” Cerebrovascular Diseases, vol. 24, no. 1, pp. 104–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. Enlimomab Acute Stroke Trial Investigator, “Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial,” Neurology, vol. 57, no. 8, pp. 1428–1434, 2001. View at Publisher · View at Google Scholar
  69. M. Krams, K. R. Lees, W. Hacke, A. P. Grieve, J.-M. Orgogozo, and G. A. Ford, “Acute stroke therapy by inhibition of neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke,” Stroke, vol. 34, no. 11, pp. 2543–2548, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Seki, Y. Sahara, E. Itoh, and T. Kawamura, “Suppressed neutrophil respiratory burst in patients with haemorrhagic stroke,” Journal of Clinical Neuroscience, vol. 17, no. 2, pp. 187–190, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. T. Molnar, A. Peterfalvi, L. Szereday et al., “Deficient leucocyte antisedimentation is related to post-stroke infections and outcome,” Journal of Clinical Pathology, vol. 61, no. 11, pp. 1209–1213, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Ruhnau, K. Schulze, B. Gaida et al., “Stroke alters respiratory burst in neutrophils and monocytes,” Stroke, vol. 45, no. 3, pp. 794–800, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. Á. Chamorro, S. Amaro, M. Vargas et al., “Catecholamines, infection, and death in acute ischemic stroke,” Journal of the Neurological Sciences, vol. 252, no. 1, pp. 29–35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. P. J. Winklewski, M. Radkowski, and U. Demkow, “Cross-talk between the inflammatory response, sympathetic activation and pulmonary infection in the ischemic stroke,” Journal of Neuroinflammation, vol. 11, no. 1, article no. 213, 2014. View at Publisher · View at Google Scholar · View at Scopus